Biosimilar use in the United States: An analysis of filgrastim and infliximab

被引：0
|
作者：
Dutcher, Sarah K. [1 ]
Eworuke, Efe [1 ]
Fazio-Eynullayeva, Elnara [2 ,3 ]
Dee, Elizabeth [2 ,3 ]
Nguyen, Michael D. [1 ]
Panozzo, Catherine A. [2 ,3 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
978
引用
收藏
页码：475 / 475
页数：1
相关论文
共 50 条
  • [21] Stem cell mobilization with filgrastim biosimilar
    Krome, Susanne
    TRANSFUSIONSMEDIZIN, 2025, 15 (01) : 14 - 14
  • [22] Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics
    Fritz Sörgel
    Arnd Schwebig
    Johann Holzmann
    Stefan Prasch
    Pritibha Singh
    Martina Kinzig
    BioDrugs, 2015, 29 : 123 - 131
  • [23] Adherence patterns in naive and prevalent use of infliximab and its biosimilar
    Alanaeme, Chibuike J.
    Sarvesh, Sujith
    Li, Cynthia Y.
    Bernatsky, Sasha
    Curtis, Jeffrey R.
    Yun, Huifeng
    BMC RHEUMATOLOGY, 2022, 6 (01)
  • [24] USE OF INFLIXIMAB BIOSIMILAR IN OUR CENTER: OUR EXPERIENCE IN PHARMACOVIGILANCE
    Geccherle, A.
    Tessari, R.
    Variola, A.
    Massella, A.
    Capoferro, E.
    Zuppini, T.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E162 - E162
  • [25] Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics
    Soergel, Fritz
    Schwebig, Arnd
    Holzmann, Johann
    Prasch, Stefan
    Singh, Pritibha
    Kinzig, Martina
    BIODRUGS, 2015, 29 (02) : 123 - 131
  • [26] Budget impact analysis of infliximab biosimilar: the Italian scenery
    Lucioni, Carlo
    Mazzi, Silvio
    Caporali, Roberto
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2015, 2 (02) : 78 - 88
  • [27] Filgrastim becomes biosimilar test case for hospitals
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (22) : 1805 - 1806
  • [28] Provider Differences in Biosimilar Uptake in the Filgrastim Market
    Chen, Alice J.
    Ribero, Rocio
    Van Nuys, Karen
    AMERICAN JOURNAL OF MANAGED CARE, 2020, 26 (05): : 208 - +
  • [29] Biosimilar filgrastim approved, but with "placeholder" generic name
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (08) : 592 - 594
  • [30] Biosimilar infliximab: an expert view
    Genazzani, A.
    Altomare, G.
    Balato, N.
    Cusano, F.
    De Pita, O.
    Loconsole, F.
    Micali, G.
    Piaserico, S.
    Girolomoni, G.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2015, 150 (04): : 449 - 459
12345